Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.8 USD | +2.51% | +4.42% | -5.18% |
06:14pm | IBM Delivers on Two Key Metrics in 'Solid' Q1 Despite Revenue Miss, RBC Says | MT |
04:13pm | BNP Paribas Adjusts Price Target on Healthpeak Properties to $21 From $19 | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 47.17 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.18% | 13.01B | A | ||
+5.02% | 55.56B | A- | ||
-11.57% | 17.46B | A- | ||
+2.17% | 7.63B | B | ||
-16.54% | 5.35B | B- | ||
+8.69% | 3.23B | C- | ||
-1.97% | 3.16B | C+ | ||
-5.42% | 3.02B | B+ | ||
-6.62% | 2.76B | C | ||
+12.80% | 2.72B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DOC Stock
- Ratings Healthpeak Properties, Inc.